117 APE patients were selected and divided into two groups according to plasma PTX-3 levels, including the group in which PTX − 3 ≥ 3.0 ng/mL (n = 42) and the group in which PTX − 3 < 3.0 ng/mL (n = 75). The gene discussed is PTX3; the disease is apparent mineralocorticoid excess.